Literature DB >> 11379893

Antifungal resistance of candidal biofilms formed on denture acrylic in vitro.

J Chandra1, P K Mukherjee, S D Leidich, F F Faddoul, L L Hoyer, L J Douglas, M A Ghannoum.   

Abstract

Denture biofilms represent a protective reservoir for oral microbes. The study of the biology of Candida in these biofilms requires a reliable model. A reproducible model of C. albicans denture biofilm was developed and used to determine the susceptibility of two clinically relevant C. albicans isolates against 4 antifungals. C. albicans, growing as a biofilm, exhibited resistance to amphotericin B, nystatin, chlorhexidine, and fluconazole, with 50% reduction in metabolic activity (50% RMA) at concentrations of 8, 16, 128, and > 64 microg/mL, respectively. In contrast, planktonically cultured C. albicans were susceptible (50% RMA for the same antifungals was obtained at 0.25, 1.0, 4.0, and 0.5 microg/mL, respectively). In conclusion, results obtained by means of our biofilm model show that biofilm-associated C. albicans cells, compared with cells grown in planktonic form, are resistant to antifungals used to treat denture stomatitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11379893     DOI: 10.1177/00220345010800031101

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  157 in total

1.  Evaluation of the morphological effects of TDT 067 (terbinafine in Transfersome) and conventional terbinafine on dermatophyte hyphae in vitro and in vivo.

Authors:  M Ghannoum; N Isham; W Henry; H-A Kroon; S Yurdakul
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

2.  Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms.

Authors:  Emeka I Nweze; Adam Ghannoum; Jyotsna Chandra; Mahmoud A Ghannoum; Pranab K Mukherjee
Journal:  J Antimicrob Chemother       Date:  2011-10-11       Impact factor: 5.790

3.  Efficacy of surface-generated nitric oxide against Candida albicans adhesion and biofilm formation.

Authors:  Benjamin J Privett; Steven T Nutz; Mark H Schoenfisch
Journal:  Biofouling       Date:  2010-11       Impact factor: 3.209

4.  Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans.

Authors:  Luis A Murillo; George Newport; Chung-Yu Lan; Stefan Habelitz; Jan Dungan; Nina M Agabian
Journal:  Eukaryot Cell       Date:  2005-09

5.  Effects of fresh garlic extract on Candida albicans biofilms.

Authors:  Jennifer A Shuford; James M Steckelberg; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 6.  Candida biofilms: an update.

Authors:  Gordon Ramage; Stephen P Saville; Derek P Thomas; José L López-Ribot
Journal:  Eukaryot Cell       Date:  2005-04

7.  Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions.

Authors:  Yoshifumi Imamura; Jyotsna Chandra; Pranab K Mukherjee; Ali Abdul Lattif; Loretta B Szczotka-Flynn; Eric Pearlman; Jonathan H Lass; Kerry O'Donnell; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

8.  Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing.

Authors:  Zhihong Xie; Angela Thompson; Takanori Sobue; Helena Kashleva; Hongbin Xu; John Vasilakos; Anna Dongari-Bagtzoglou
Journal:  J Infect Dis       Date:  2012-10-02       Impact factor: 5.226

Review 9.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Shear stress modulates the thickness and architecture of Candida albicans biofilms in a phase-dependent manner.

Authors:  Pranab K Mukherjee; David V Chand; Jyotsna Chandra; James M Anderson; Mahmoud A Ghannoum
Journal:  Mycoses       Date:  2008-12-09       Impact factor: 4.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.